These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1625008)

  • 21. Recanalization of spinal arteriovenous malformations following embolization.
    Hall WA; Oldfield EH; Doppman JL
    J Neurosurg; 1989 May; 70(5):714-20. PubMed ID: 2709112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroradiologic interventional procedures.
    Berenstein A; Kricheff II
    Semin Roentgenol; 1981 Apr; 16(2):79-94. PubMed ID: 7233249
    [No Abstract]   [Full Text] [Related]  

  • 23. Dominant-hemisphere arteriovenous malformations: therapeutic embolization with isobutyl-2-cyanoacrylate.
    Viñuela FV; Debrun GM; Fox AJ; Girvin JP; Peerless SJ
    AJNR Am J Neuroradiol; 1983; 4(4):959-66. PubMed ID: 6410882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathology of arteriovenous malformations embolized with isobutyl-2-cyanoacrylate (bucrylate). Report of two cases.
    Vinters HV; Debrun G; Kaufmann JC; Drake CG
    J Neurosurg; 1981 Nov; 55(5):819-25. PubMed ID: 7310505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraarterial sodium amytal administration to guide preoperative embolization of cerebral arteriovenous malformations.
    Purdy PD; Batjer HH; Samson D; Risser RC; Bowman GW
    J Neurosurg Anesthesiol; 1991 Jun; 3(2):103-6. PubMed ID: 15815388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissolution of isobutyl 2-cyanoacrylate on long-term follow-up.
    Rao VR; Mandalam KR; Gupta AK; Kumar S; Joseph S
    AJNR Am J Neuroradiol; 1989; 10(1):135-41. PubMed ID: 2492713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multimodality treatment of brain arteriovenous malformations with microsurgery after embolization with onyx: single-center experience and technical nuances.
    Natarajan SK; Ghodke B; Britz GW; Born DE; Sekhar LN
    Neurosurgery; 2008 Jun; 62(6):1213-25; discussion 1225-6. PubMed ID: 18824988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calibrated leak balloon microcatheter: a device for arterial exploration and occlusive therapy.
    Kerber CW; Bank WO; Cromwell LD
    AJR Am J Roentgenol; 1979 Feb; 132(2):207-12. PubMed ID: 105585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Congested residual nidus after preoperative intranidal embolization in midsize cerebral arteriovenous malformations of 3-6 cm in diameter.
    Steiger HJ; Brückmann H; Mayer T; Schmid-Elsaesser R; Zausinger S
    Acta Neurochir (Wien); 2004 Jul; 146(7):649-57. PubMed ID: 15197607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term pathological follow-up of cerebral arteriovenous malformations treated by embolization with bucrylate.
    Vinters HV; Lundie MJ; Kaufmann JC
    N Engl J Med; 1986 Feb; 314(8):477-83. PubMed ID: 3511383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. n-Butyl 2-cyanoacrylate--substitute for IBCA in interventional neuroradiology: histopathologic and polymerization time studies.
    Brothers MF; Kaufmann JC; Fox AJ; Deveikis JP
    AJNR Am J Neuroradiol; 1989; 10(4):777-86. PubMed ID: 2505505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraoperative embolisation of cerebral arteriovenous malformations with isobutyl-2-cyanoacrylate (bucrylate).
    de Lange JJ; Baerts WD; Pearce C
    Acta Anaesthesiol Belg; 1982; 33(3):211-4. PubMed ID: 6815977
    [No Abstract]   [Full Text] [Related]  

  • 33. Stereotactic radiosurgery for arteriovenous malformations of the brain.
    Lunsford LD; Kondziolka D; Flickinger JC; Bissonette DJ; Jungreis CA; Maitz AH; Horton JA; Coffey RJ
    J Neurosurg; 1991 Oct; 75(4):512-24. PubMed ID: 1885968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting cerebral arteriovenous malformations for minimally invasive therapy.
    Alexander MJ; Tolbert ME
    Neurosurgery; 2006 Nov; 59(5 Suppl 3):S178-83; discussion S3-13. PubMed ID: 17053601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethyl 2-cyanoacrylate as an embolic agent for cranial arteriovenous malformations. An experimental study.
    Katada K; Sano H; Katoh Y; Kanno T; Jain VK; Mashita S; Takeuchi A; Koga S
    Acta Radiol Suppl; 1986; 369():623-6. PubMed ID: 2980576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of cerebral arteriovenous malformations with PVA. Results and analysis of complications.
    Schumacher M; Horton JA
    Neuroradiology; 1991; 33(2):101-5. PubMed ID: 2046890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic embolization of arteriovenous malformations: the case for and against.
    Martin NA; Khanna R; Doberstein C; Bentson J
    Clin Neurosurg; 2000; 46():295-318. PubMed ID: 10944685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intravascular embolization in treatment of craniocerebral vascular diseases].
    Wu ZX
    Zhonghua Wai Ke Za Zhi; 1993 Jan; 31(1):8-12. PubMed ID: 8404348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preembolization superselective angiography: role in the treatment of brain arteriovenous malformations with isobutyl-2 cyanoacrylate.
    Viñuela F; Fox AJ; Debrun G; Pelz D
    AJNR Am J Neuroradiol; 1984; 5(6):765-9. PubMed ID: 6437178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary emboli following therapeutic embolization of cerebral arteriovenous malformations in children.
    Kjellin IB; Boechat MI; Vinuela F; Westra SJ; Duckwiler GR
    Pediatr Radiol; 2000 Apr; 30(4):279-83. PubMed ID: 10789913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.